-
公开(公告)号:US12029645B2
公开(公告)日:2024-07-09
申请号:US17234266
申请日:2021-04-19
发明人: Robert G Matheny
CPC分类号: A61F2/2418 , A61F2/2436 , A61L27/3604 , A61L27/54 , A61L31/08 , A61L31/14 , A61F2/9522 , A61F2220/0016 , A61L27/3629 , A61L2300/406 , A61L2430/20
摘要: A percutaneous transcatheter valve delivery method for replacing a dysfunctional heart valve; particularly, an atrioventricular (AV) valve, with a prosthetic valve comprising a base valve structure and a stent structure. The transcatheter implantation method accurately positions and securely engages the prosthetic valve in a valve annulus region.
-
公开(公告)号:US20220008623A1
公开(公告)日:2022-01-13
申请号:US17482674
申请日:2021-09-23
发明人: Robert G. Matheny
IPC分类号: A61L27/54 , A61K48/00 , A61L27/36 , A61L27/38 , A61K35/38 , A61L27/40 , A61K38/17 , A61K38/18 , A61K35/34 , A61K35/545 , A61K31/726 , A61K31/7088 , A61K35/37 , A61K35/407 , A61K35/22 , A61K38/39 , A61L27/58 , A61K35/50 , A61L27/22
摘要: A method for treating damaged or diseased mammalian tissue that includes the steps of (i) providing a sheet structure formed from acellular dermal mammalian tissue that includes extracellular matrix (ECM) and a supplemental bioactive component, such as a nucleic acid, and/or a cell, and (ii) delivering the sheet structure to the damaged or diseased mammalian tissue, wherein the sheet structure induces angiogenesis and, thereby, regeneration of new mammalian tissue.
-
公开(公告)号:US11154395B2
公开(公告)日:2021-10-26
申请号:US16553499
申请日:2019-08-28
发明人: Robert G Matheny
IPC分类号: A61F2/24 , A61K31/165 , A61K31/4164 , A61K31/43 , A61K31/47 , A61K31/505 , A61K31/65 , A61K31/702 , A61K31/7028 , A61K31/7048 , A61K31/7056 , A61K38/14 , A61L27/18 , A61L27/58
摘要: A prosthetic valve comprising a conical shaped ribbon structure comprising a polymeric composition. The ribbon structure comprises a plurality of elongated ribbon members that are positioned proximate each other in a joined relationship, wherein the ribbon members are positioned adjacent each other and form a plurality of fluid flow modulating regions that open when fluid flow through the valve exhibits a negative flow pressure and open when fluid flow through the valve exhibits a positive flow pressure.
-
公开(公告)号:US20210316042A1
公开(公告)日:2021-10-14
申请号:US17358616
申请日:2021-06-25
发明人: Robert G. Matheny
IPC分类号: A61L27/36 , A61F2/06 , A61F2/00 , A61L27/34 , A61L27/54 , A61L27/58 , A61K31/4418 , A61L27/38 , A61L27/50
摘要: Biomaterial compositions for treating, reconstructing and replacing damaged or diseased cardiovascular tissue that include a plurality of particulate structures. The biomaterial compositions include poly(glycerol sebacate) (PGS) and an antifibrotic. The biomaterial compositions can also include poly(glycerol sebacate) acrylate (PGSA) and an antifibrotic. The biomaterial compositions can further include acellular extracellular matrix (ECM) derived from a mammalian tissue source, such as small intestine submucosa, cardiac tissue and placental tissue. The biomaterial compositions are adapted to modulate inflammation of damaged tissue and induce neovascularization, host cell proliferation, remodeling of damaged tissue, and regeneration of new tissue and tissue structures.
-
公开(公告)号:US20210228346A1
公开(公告)日:2021-07-29
申请号:US17231229
申请日:2021-04-15
发明人: Robert G Matheny
IPC分类号: A61F2/24
摘要: A biocompatible and biodegradable construct comprising a base expandable member and an outer coating comprising poly(glycerol sebacate) (PGS), the base expandable member comprising acellular extracellular matrix (ECM) derived from a mammalian tissue source, the acellular ECM exhibiting a flexible, porous, expandable structure, which is adapted to expand upon exposure to and absorption of a bodily fluid, wherein the construct seals a perivalvular leak when disposed proximate thereto.
-
公开(公告)号:US20210196859A1
公开(公告)日:2021-07-01
申请号:US17178406
申请日:2021-02-18
发明人: Robert G. Matheny
IPC分类号: A61L27/36 , A61F2/06 , A61F2/00 , A61L27/34 , A61L27/54 , A61L27/58 , A61K31/4418 , A61L27/38 , A61L27/50
摘要: Cardiovascular prostheses for treating, reconstructing and replacing damaged or diseased cardiovascular tissue that include a plurality of particulate structures. The particulate structures further include an acellular ECM core and an outer layer or coating comprising poly(glycerol sebacate) (PGS) and everolimus. When the particulate structures are delivered to the damaged cardiovascular tissue the outer layer is adapted to induce a first level of remodeling and suppress hyperplasia, and the acellular ECM is adapted to induce a second level of remodeling.
-
公开(公告)号:US20210169644A1
公开(公告)日:2021-06-10
申请号:US17181161
申请日:2021-02-22
发明人: Robert G Matheny
摘要: Prosthetic valves that include conical shaped base valve members having an annular engagement end, a closed distal end region that restricts fluid flow therethrough, and a plurality of elongated ribbon members, which transition from an open fluid flow configuration to a closed fluid flow configuration in response to expansion and contraction of the base valve member, and a support structure that is configured and adapted to exert retaining forces on the annular engagement ends of the base valve members, whereby the support structure (i) conforms to the shape of the annular engagement ends of the base valve members, (ii) securely positions the annular engagement ends of the base valve members adjacent to and, thereby, in contact with a valve annulus, whereby the annular engagement ends of the base valve members conform to the shape of the valve annulus, and (iii) the annular engagement ends of the base valve members adapt to at least one fluctuation in the configuration and/or dimension of the valve annulus, whereby the annular engagement ends of the base valve members maintain contact therewith.
-
公开(公告)号:US20200376169A1
公开(公告)日:2020-12-03
申请号:US16990350
申请日:2020-08-11
发明人: Robert G. Matheny
IPC分类号: A61L27/54 , A61K48/00 , A61L27/36 , A61L27/38 , A61K35/38 , A61L27/40 , A61K38/17 , A61K38/18 , A61K35/34 , A61K35/545 , A61K31/726 , A61K31/7088 , A61K35/37 , A61K35/407 , A61K35/22 , A61K38/39 , A61L27/58 , A61K35/50 , A61L27/22
摘要: Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.
-
公开(公告)号:US20200069840A1
公开(公告)日:2020-03-05
申请号:US16440504
申请日:2019-06-13
发明人: Robert G. Matheny
摘要: A prosthetic valve comprising a conical shaped ribbon structure comprising an extracellular matrix (ECM) composition. The ribbon structure comprises a plurality of elongated ribbon members that are positioned proximate each other in a joined relationship, wherein the ribbon members are positioned adjacent each other and form a plurality of fluid flow modulating regions that open when fluid flow through the valve exhibits a negative flow pressure and open when fluid flow through the valve exhibits a positive flow pressure.
-
公开(公告)号:US20190351101A1
公开(公告)日:2019-11-21
申请号:US16531263
申请日:2019-08-05
发明人: Robert G. Matheny
IPC分类号: A61L27/36 , A61L27/50 , A61L27/54 , A61F2/06 , A61K31/4418 , A61L27/34 , A61L27/58 , A61F2/00 , A61L27/38
摘要: Cardiovascular prostheses for treating, reconstructing and replacing damaged or diseased cardiovascular tissue that are formed from acellular extracellular matrix (ECM). The cardiovascular prostheses comprise various compositions, such as poly(glycerol sebacate (PGS) or ECM based compositions, and structures, such as particulate structures, mesh constructs, encasement structures, coated structures and multi-sheet laminate structures.
-
-
-
-
-
-
-
-
-